Literature DB >> 31010740

RETRACTED: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast Cancer

Cheng-Cao Sun1, Shu-Jun Li2, Wei Hu3, Jian Zhang3, Qun Zhou3, Cong Liu3, Lin-Lin Li3, Yi-Yan Songyang3, Feng Zhang3, Zhen-Long Chen4, Guang Li5, Zhuo-Yue Bi6, Yong-Yi Bi3, Feng-Yun Gong7, Tao Bo7, Zhan-Peng Yuan3, Wei-Dong Hu8, Bo-Tao Zhan9, Qian Zhang10, Qi-Qiang He11, De-Jia Li12.   

Abstract

Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  E2Fs; Kaplan-Meier Plotter; biomarkers; breast cancer; prognosis

Mesh：

Substances：

Year:  2019        PMID： 31010740      PMCID： PMC6554685          DOI： 10.1016/j.ymthe.2019.03.019

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


  45 in total

1.  In vivo disruption of an Rb-E2F-Ezh2 signaling loop causes bladder cancer.

Authors:  Mirentxu Santos; Mónica Martínez-Fernández; Marta Dueñas; Ramón García-Escudero; Begoña Alfaya; Felipe Villacampa; Cristina Saiz-Ladera; Clotilde Costa; Marta Oteo; José Duarte; Victor Martínez; Mª José Gómez-Rodriguez; Mª Luisa Martín; Manoli Fernández; Patrick Viatour; Miguel A Morcillo; Julien Sage; Daniel Castellano; Jose L Rodriguez-Peralto; Federico de la Rosa; Jesús M Paramio
Journal:  Cancer Res       Date:  2014-09-24       Impact factor: 12.701

2.  Circular RNA hsa_circ_0008039 promotes breast cancer cell proliferation and migration by regulating miR-432-5p/E2F3 axis.

Authors:  Yanhua Liu; Cuntao Lu; Yizhou Zhou; Zhihong Zhang; Li Sun
Journal:  Biochem Biophys Res Commun       Date:  2018-05-31       Impact factor: 3.575

3.  MicroRNA-129-3p suppresses tumor growth by targeting E2F5 in glioblastoma.

Authors:  D-Z Fang; Y-P Wang; J Liu; X-B Hui; X-D Wang; X Chen; D Liu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-02       Impact factor: 3.507

4.  E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control.

Authors:  S Gaubatz; G J Lindeman; S Ishida; L Jakoi; J R Nevins; D M Livingston; R E Rempel
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

5.  Identification of tumor suppressive role of microRNA-132 and its target gene in tumorigenesis of prostate cancer.

Authors:  Shun-Lai Li; Ying Sui; Jie Sun; Ting-Qi Jiang; Gang Dong
Journal:  Int J Mol Med       Date:  2018-01-23       Impact factor: 4.101

6.  E2F2 induction in related to cell proliferation and poor prognosis in non-small cell lung carcinoma.

Authors:  Li Chen; Jian Hua Yu; Zhi Hui Lu; Wei Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis.

Authors:  Emad A Rakha; Sarah E Pinder; E Claire Paish; John F Robertson; Ian O Ellis
Journal:  J Pathol       Date:  2004-07       Impact factor: 7.996

Review 8.  Atypical E2Fs: new players in the E2F transcription factor family.

Authors:  Tim Lammens; Jing Li; Gustavo Leone; Lieven De Veylder
Journal:  Trends Cell Biol       Date:  2009-02-07       Impact factor: 20.808

9.  Conserved E2F mediated metastasis in mouse models of breast cancer and HER2 positive patients.

Authors:  Jonathan Rennhack; Eran Andrechek
Journal:  Oncoscience       Date:  2015-11-10

10.  Upregulation of E2F8 promotes cell proliferation and tumorigenicity in breast cancer by modulating G1/S phase transition.

Authors:  Liping Ye; Ling Guo; Zhenyu He; Xi Wang; Chuyong Lin; Xin Zhang; Shu Wu; Yong Bao; Qi Yang; Libing Song; Huanxin Lin
Journal:  Oncotarget       Date:  2016-04-26
View more
  64 in total

1.  LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancer.

Authors:  A Giro-Perafita; L Luo; A Khodadadi-Jamayran; M Thompson; B Akgol Oksuz; A Tsirigos; B D Dynlacht; I Sánchez; F J Esteva
Journal:  NPJ Breast Cancer       Date:  2020-01-06

2.  Abnormal spindle-like microcephaly-associated protein promotes proliferation by regulating cell cycle in epithelial ovarian cancer.

Authors:  Yiguo Wu; Yujuan You; Ling Chen; Yue Liu; Yujuan Liu; Weiming Lou; Fen Fu
Journal:  Gland Surg       Date:  2022-04

3.  Circ_0004676 exacerbates triple-negative breast cancer progression through regulation of the miR-377-3p/E2F6/PNO1 axis.

Authors:  Guoli Shao; Xulong Fan; Pusheng Zhang; Xuewen Liu; Lei Huang; Shufeng Ji
Journal:  Cell Biol Toxicol       Date:  2022-07-23       Impact factor: 6.819

4.  circCAMSAP1 Promotes Tumor Growth in Colorectal Cancer via the miR-328-5p/E2F1 Axis.

Authors:  Chi Zhou; Hua-Shan Liu; Feng-Wei Wang; Tuo Hu; Zhen-Xing Liang; Nan Lan; Xiao-Wen He; Xiao-Bin Zheng; Xiao-Jian Wu; Dan Xie; Xian-Rui Wu; Ping Lan
Journal:  Mol Ther       Date:  2019-12-25       Impact factor: 11.454

5.  Integrated Analysis of the Prognosis-Associated RNA-Binding Protein Genes and Candidate Drugs in Renal Papillary Cell Carcinoma.

Authors:  Silin Jiang; Xiaohan Ren; Shouyong Liu; Zhongwen Lu; Aiming Xu; Chao Qin; Zengjun Wang
Journal:  Front Genet       Date:  2021-02-12       Impact factor: 4.599

6.  ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis.

Authors:  Geting Wu; Yuanliang Yan; Yuan Cai; Bi Peng; Juanni Li; Jinzhou Huang; Zhijie Xu; Jianhua Zhou
Journal:  Front Cell Dev Biol       Date:  2021-06-03

7.  The RNA-Binding Protein NELFE Promotes Gastric Cancer Growth and Metastasis Through E2F2.

Authors:  Changyu Chen; Qiang Zheng; Shubo Pan; Wenzheng Chen; Jianfeng Huang; Yi Cao; Yi Tu; Zhengrong Li; Changjun Yu; Zhigang Jie
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

8.  FSTL3 is a Prognostic Biomarker in Gastric Cancer and is Correlated with M2 Macrophage Infiltration.

Authors:  Yuan-Jie Liu; Jie-Pin Li; Ying Zhang; Meng-Jun Nie; Yong-Hua Zhang; Shen-Lin Liu; Xi Zou
Journal:  Onco Targets Ther       Date:  2021-07-06       Impact factor: 4.147

9.  NMU Is a Poor Prognostic Biomarker in Patients with Lung Adenocarcinoma.

Authors:  Yan Tang; Chunsheng Hu
Journal:  Dis Markers       Date:  2021-07-12       Impact factor: 3.434

10.  Prognostic Values of E2F1/2 Transcriptional Expressions in Chromophobe Renal Cell Carcinoma Patients: Evidence from Bioinformatics Analysis.

Authors:  Dingtao Hu; Nana Meng; Xiaoqi Lou; Zhen Li; Ying Teng; Bizhi Tu; Yanfeng Zou; Fang Wang
Journal:  Int J Gen Med       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.